Cargando…
Identification of a four-gene panel predicting overall survival for lung adenocarcinoma
BACKGROUND: Lung cancer is the most frequently diagnosed carcinoma and the leading cause of cancer-related mortality. Although molecular targeted therapy and immunotherapy have made great progress, the overall survival (OS) is still poor due to a lack of accurate and available prognostic biomarkers....
Autores principales: | Li, Chunyu, Long, Qizhong, Zhang, Danni, Li, Jun, Zhang, Xianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720456/ https://www.ncbi.nlm.nih.gov/pubmed/33287749 http://dx.doi.org/10.1186/s12885-020-07657-9 |
Ejemplares similares
-
Identification of a circadian gene signature that predicts overall survival in lung adenocarcinoma
por: Gao, Xinliang, et al.
Publicado: (2021) -
A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2021) -
Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma
por: Cao, Yubo, et al.
Publicado: (2020) -
Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma
por: Dong, Zheng, et al.
Publicado: (2021) -
Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)